Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics

References

• Read NW, Sugden K. (1988). Gastrointestinal dynamics and pharmacology for the optimum design of controlled-release oral dosage forms. Crit Rev Ther Drug Carrier Syst, 4:221–263.
   PubMed Web of Science ®Google Scholar
• Vishwanathan S. (2005). The latest in POP (tablet) technology. Pharm Formulation Quality, 7:32–34.
   Google Scholar
• Singh BN. (1999). Effects of food on clinical pharmacokinetics. Clin Pharmacokinet, 37:213–255.
   PubMed Web of Science ®Google Scholar
• Fleisher D, Li C, Zhou Y, Pao LH, Karim A. (1999). Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet, 36:233–254.
   PubMed Web of Science ®Google Scholar
• CDER. (2002). Guidance for Industry: Food-Effect Bioavailability and Fed Bioequivalence Studies. Vol. 2004–2005, FDA.
   Google Scholar
• Marasanapalle VP, Crison JR, Ma J, Li X, Jasti BR. (2009). Investigation of some factors contributing to negative food effects. Biopharm Drug Dispos, 30:71–80.
   PubMed Web of Science ®Google Scholar
• Timmer CJ, Huisman JA. (2002). Effect of a standardized meal on the bioavailability of a single oral dose of tibolone 2.5 mg in healthy postmenopausal women. Pharmacotherapy, 22:310–315.
   PubMed Web of Science ®Google Scholar
• Li Z, Vachharajani NN, Krishna R. (2002). On the assessment of effects of food on the pharmacokinetics of drugs in early development. Biopharm Drug Dispos, 23:165–171.
   PubMed Web of Science ®Google Scholar
• Charman WN, Porter CJ, Mithani S, Dressman JB. (1997). Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci, 86:269–282.
   PubMed Web of Science ®Google Scholar
• Singh BN. (2005). A quantitative approach to probe the dependence and correlation of food-effect with aqueous solubility, dose/solubility ratio, and partition coefficient (Log P) for orally active drugs administered as immediate-release formulations. Drug Dev Res, 65:55–75.
   Web of Science ®Google Scholar
• Gu CH, Li H, Levons J, Lentz K, Gandhi RB, Raghavan K et al. (2007). Predicting effect of food on extent of drug absorption based on physicochemical properties. Pharm Res, 24:1118–1130.
   PubMed Web of Science ®Google Scholar
• Deppermann KM, Lode H. (1993). Fluoroquinolones: interaction profile during enteral absorption. Drugs, 45 (Suppl 3):65–72.
   PubMedGoogle Scholar
• Neuvonen PJ, Kivistö KT. (1989). The clinical significance of food–drug interactions: a review. Med J Aust, 150:36–40.
   PubMed Web of Science ®Google Scholar
• Humberstone AJ, Porter CJ, Charman WN. (1996). A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. J Pharm Sci, 85:525–529.
   PubMed Web of Science ®Google Scholar
• Wagstaff AJ. (2006). Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension. Drugs, 66:1881–1901.
   PubMed Web of Science ®Google Scholar
• Novartis. (2006). In US Prescribing Information. Pharmaceuticals Corporation, Novartis, East Hanover, NJ.
   Google Scholar
• Wu CY, Benet LZ. (2005). Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res, 22:11–23.
   PubMed Web of Science ®Google Scholar
• Young AM, Audus KL, Proudfoot J, Yazdanian M. (2006). Tetrazole compounds: the effect of structure and pH on Caco-2 cell permeability. J Pharm Sci, 95:717–725.
   PubMed Web of Science ®Google Scholar
• Jonkman JH, van der Boon WJ, Balant LP, Le Cotonnec JY. (1985). Food reduces the rate but not the extent of the absorption of theophylline from an aqueous solution. Eur J Clin Pharmacol, 28:225–227.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Johnson N, Castelo J, Sinko PJ, Grass G, Holme K et al. (2005). Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer. Eur J Pharm Sci, 25:193–200.
   PubMed Web of Science ®Google Scholar
• Mäntylä R, Männistö P, Nykänen S, Koponen A, Lamminsivu U. (1983). Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers. Eur J Clin Pharmacol, 24:227–230.
   PubMed Web of Science ®Google Scholar
• Avdeef A. (2001). Physicochemical profiling (solubility, permeability and charge state). Curr Top Med Chem, 1:277–351.
   PubMedGoogle Scholar
• Dressman JB, Berardi RR, Dermentzoglou LC, Russell TL, Schmaltz SP, Barnett JL et al. (1990). Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res, 7:756–761.
   PubMed Web of Science ®Google Scholar
• Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. (1998). Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res, 15:698–705.
   PubMed Web of Science ®Google Scholar
• JRH Biosciences I. (2000). Hanks’ Balanced Salt Solution (HBSS)–MSDS Vol. 2005. JRH Biosciences, Inc., Lenexa, KS.
   Google Scholar
• Levis KA, Lane ME, Corrigan OI. (2003). Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen. Int J Pharm, 253:49–59.
   PubMed Web of Science ®Google Scholar
• Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS et al. (2004). Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm, 1:85–96.
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. (2005). pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ. J Pharm Sci, 94:2632–2643.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT, Sheen PC, Mufson D, Bernstein DF, Augustine MA. (1986). Preformulation study of a poorly water-soluble drug, alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: selection of the base for dosage form design. J Pharm Sci, 75:492–496.
   PubMed Web of Science ®Google Scholar
• Crison JR, Weiner ND, Amidon GL. (1997). Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J Pharm Sci, 86:384–388.
   PubMed Web of Science ®Google Scholar
• Li J, Carr PW. (1997). Accuracy of empirical correlations for estimating diffusion coefficients in aqueous organic mixtures. Anal Chem, 69:2530–2536.
   PubMed Web of Science ®Google Scholar
• Poling BE, Prausnitz JM, O’Connell JP. (2003). The Properties of Gases and Liquids. McGraw-Hill Companies, Inc., New York.
   Google Scholar
• Oh DM, Curl RL, Amidon GL. (1993). Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm Res, 10:264–270.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Kokate A, Li X, Williams PJ, Singh P, Jasti BR. (2009). In silico prediction of drug permeability across buccal mucosa. Pharm Res, 26:1130–1139.
   PubMed Web of Science ®Google Scholar
• Campbell MJ. (2001). Statistics at Square Two: Understanding Modern Statistical Applications in Medicine. BML Publishing group, London.
   Google Scholar
• Blume HH, Schug BS. (1999). The biopharmaceutics classification system (BCS): class III drugs—better candidates for BA/BE waiver? Eur J Pharm Sci, 9:117–121.
   PubMed Web of Science ®Google Scholar
• Pao LH, Zhou SY, Cook C, Kararli T, Kirchhoff C, Truelove J et al. (1998). Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. Pharm Res, 15:221–227.
   PubMed Web of Science ®Google Scholar
• Lee KH, Xu GX, Schoenhard GL, Cook CS. (1997). Mechanisms of food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide in the rat. Pharm Res, 14:1030–1038.
   PubMed Web of Science ®Google Scholar
• Cook CS, Zhang L, Osis J, Schoenhard GL, Karim A. (1998). Mechanism of compound- and species-specific food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide. Pharm Res, 15:429–433.
   PubMed Web of Science ®Google Scholar
• Marathe PH, Greene DS, Kollia GD, Barbhaiya RH. (1998). Evaluation of the effect of food on the pharmacokinetics of avitriptan. Biopharm Drug Dispos, 19:381–394.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT, Pudipeddi M. (2002). Salt-selection strategies. In Handbook of Pharmaceutical Salts. Stahl HP, Wermuth CG, eds. Wiley-VCH, Zurich, Switzerland and Weinheim, Germany, pp. 135–160
   Google Scholar
• Kararli TT. (1995). Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos, 16:351–380.
   PubMed Web of Science ®Google Scholar
• Hörter D, Dressman JB. (2001). Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev, 46:75–87.
   PubMed Web of Science ®Google Scholar
• Lindenberg M, Kopp S, Dressman JB. (2004). Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm, 58:265–278.
   PubMed Web of Science ®Google Scholar
• Melander A, Stenberg P, Liedholm H, Scherstén B, Wåhlin-Boll E. (1979). Food-induced reduction in bioavailability of atenolol. Eur J Clin Pharmacol, 16:327–330.
   PubMed Web of Science ®Google Scholar
• Buice RG, Subramanian VS, Duchin KL, Uko-Nne S. (1996). Bioequivalence of a highly variable drug: an experience with nadolol. Pharm Res, 13:1109–1115.
   PubMed Web of Science ®Google Scholar
• Tavelin S, Taipalensuu J, Söderberg L, Morrison R, Chong S, Artursson P. (2003). Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers. Pharm Res, 20:397–405.
   PubMed Web of Science ®Google Scholar
• Pan HY, DeVault AR, Brescia D, Willard DA, McGovern ME, Whigan DB et al. (1993). Effect of food on pravastatin pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther Toxicol, 31:291–294.
   PubMed Web of Science ®Google Scholar
• Beermann B, Midskov C. (1986). Reduced bioavailability and effect of furosemide given with food. Eur J Clin Pharmacol, 29:725–727.
   PubMed Web of Science ®Google Scholar
• Welty DF, Siedlik PH, Posvar EL, Selen A, Sedman AJ. (1994). The temporal effect of food on tacrine bioavailability. J Clin Pharmacol, 34:985–988.
   PubMed Web of Science ®Google Scholar
• Caille G, du Souich P, Besner JG, Gervais P, Vezina M. (1990). Effects of food and sucralfate on the pharmacokinetics of naproxen and ketoprofen in humans. Am J Med, 89:838.
   Google Scholar
• Aoyagi N, Kaniwa N, Ogata H. (1990). Effects of food on bioavailability of two indomethacin capsules containing different sizes of particles. Chem Pharm Bull, 38:1338–1340.
   PubMed Web of Science ®Google Scholar
• Pade V, Stavchansky S. (1997). Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm Res, 14:1210–1215.
   PubMed Web of Science ®Google Scholar
• Du Souich P, Lery N, Lery L, Varin F, Boucher S, Vezina M et al. (1990). Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules. Biopharm Drug Dispos, 11:137–147.
   PubMed Web of Science ®Google Scholar
• Levine MA, Walker SE, Paton TW. (1992). The effect of food or sucralfate on the bioavailability of S(+) and R(−) enantiomers of ibuprofen. J Clin Pharmacol, 32:1110–1114.
   PubMed Web of Science ®Google Scholar
• Salama NN, Scott KR, Eddington ND. (2004). DM27, an enaminone, modifies the in vitro transport of antiviral therapeutic agents. Biopharm Drug Dispos, 25:227–236.
   PubMed Web of Science ®Google Scholar
• Taylor S, Pereira AS. (2001). Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex Transm Infect, 77:4–11.
   PubMed Web of Science ®Google Scholar
• Beermann B, Groschinsky-Grind M. (1978). Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. Eur J Clin Pharmacol, 13:125–128.
   PubMed Web of Science ®Google Scholar
• Terhaag B, Gramatte T, Hrdlcka P, Richter K, Feller K. (1991). The influence of food on the absorption of diclofenac as a pure substance. Int J Clin Pharmacol Ther Toxicol, 29:418–421.
   PubMedGoogle Scholar